Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,775,442 | 296,060 | 192,580 | 1,265,909 | 1,368,782 |
| Cost of Goods | 173,348 | 86,729 | 88,283 | 260,459 | 196,718 |
| Gross Profit | 1,602,094 | 209,331 | 104,297 | 1,005,450 | 1,172,064 |
| Operating Expenses | 1,657,264 | 778,909 | 667,254 | 848,491 | 1,161,236 |
| Operating Income | -54,821 | -568,849 | -562,674 | 157,418 | 11,546 |
| Interest Expense | 29,456 | 7,946 | 35,714 | 7,889 | 8,797 |
| Other Income | 113,150 | 119,650 | 129,159 | 170,626 | 171,758 |
| Pre-tax Income | 28,872 | -457,145 | -469,229 | 320,156 | 174,507 |
| Income Tax | 62,419 | -18,277 | -31,184 | 45,884 | -43,324 |
| Net Income Continuous | -33,547 | -438,868 | -438,045 | 274,272 | 217,831 |
| Net Income | $-33,547 | $-438,868 | $-438,045 | $274,272 | $217,831 |
| EPS Basic Total Ops | -0.14 | -1.82 | -1.82 | 1.14 | 0.90 |
| EPS Basic Continuous Ops | -0.14 | -1.82 | -1.82 | 1.14 | 0.90 |
| EPS Diluted Total Ops | -0.14 | -1.82 | -1.82 | 1.15 | 0.89 |
| EPS Diluted Continuous Ops | -0.14 | -1.82 | -1.82 | 1.15 | 0.89 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -1.82 | -1.82 | 1.15 | 0.89 |
| EBITDA(a) | $93,517 | $-507,457 | $-517,585 | $334,077 | $62,370 |